tiprankstipranks
Advertisement
Advertisement
Arcus Biosciences Opens New Front With First-In-Human Trial of AB102
PremiumCompany AnnouncementsArcus Biosciences Opens New Front With First-In-Human Trial of AB102
1M ago
Arcus Biosciences Stockholders Back Directors and Governance Measures
Premium
Company Announcements
Arcus Biosciences Stockholders Back Directors and Governance Measures
2M ago
Arcus Biosciences Advances Casdatifan With New Phase 1 Bioequivalence Study
Premium
Company Announcements
Arcus Biosciences Advances Casdatifan With New Phase 1 Bioequivalence Study
2M ago
Arcus Biosciences price target raised to $22 from $20 at Morgan Stanley
PremiumThe FlyArcus Biosciences price target raised to $22 from $20 at Morgan Stanley
3M ago
Arcus Biosciences Bets Big on Cascadifan
Premium
Company Announcements
Arcus Biosciences Bets Big on Cascadifan
3M ago
Arcus Advances Quemliclustat With Completed Phase 1 Metabolism Study
Premium
Company Announcements
Arcus Advances Quemliclustat With Completed Phase 1 Metabolism Study
3M ago
Balanced Risk Profile After TIGIT Failure and Gilead Exit Supports Neutral Stance on Arcus
PremiumRatingsBalanced Risk Profile After TIGIT Failure and Gilead Exit Supports Neutral Stance on Arcus
3M ago
Arcus Biosciences discontinues Star-121 study with Gilead due to futility
Premium
The Fly
Arcus Biosciences discontinues Star-121 study with Gilead due to futility
3M ago
Arcus Biosciences price target lowered to $47 from $49 at Leerink
Premium
The Fly
Arcus Biosciences price target lowered to $47 from $49 at Leerink
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100